Table 3.
Calculations for evaluation of FIB-4 as a sole marker of fibrosis in females
| FIB-4 ≥1.32 | FIB-4 <1.32 | Total | |
| Fibroscan ≥6 kPa | 6 (15%) | 2 (5%) | 8 (20%) |
| Fibroscan <6 kPa | 10 (24%) | 23 (56%) | 33 (80%) |
| Total | 16 (39%) | 25 (61%) | 41 (100%) |
Calculations for evaluation of FIB-4 as a sole marker of fibrosis in females
| FIB-4 ≥1.32 | FIB-4 <1.32 | Total | |
| Fibroscan ≥6 kPa | 6 (15%) | 2 (5%) | 8 (20%) |
| Fibroscan <6 kPa | 10 (24%) | 23 (56%) | 33 (80%) |
| Total | 16 (39%) | 25 (61%) | 41 (100%) |